Clinical Trial Update: Nanopore Sequencing in Ophthalmology

View source ↗

Summary

A clinical trial update describing a nanopore sequencing study in ophthalmology for Endophthalmitis, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endophthalmitis

Snippet

Sponsor: Medical University of Graz | Conditions: Endophthalmitis | Status: RECRUITING